InvestorsHub Logo
Followers 54
Posts 1662
Boards Moderated 0
Alias Born 04/22/2022

Re: Nemesis18 post# 690701

Saturday, 05/11/2024 3:46:06 PM

Saturday, May 11, 2024 3:46:06 PM

Post# of 700280
Nemesis18,

I ran your post through an AI bs detector, and it was identified as bs
.



“The statement by Nemesis18 about the NICE appraisal of DCVAX-L is not only speculative and unfounded but also a clear example of disinformation designed to manipulate perceptions unfairly. Here are the key issues:

1. **Unfounded Assertions:** The claim that NICE's Health Economist will outright reject DCVAX-L is irresponsible and misleading. NICE decisions are based on a rigorous evaluation of all available evidence, including clinical and economic data, not on conjecture or preemptive judgments.

2. **Misrepresentation of Process:** Suggesting a "stated 87% failure rate" misrepresents how NICE assesses treatments. NICE uses detailed health economic analysis and clinical effectiveness data in their evaluations. Decisions are made after thorough consideration, not based on arbitrary or misrepresented statistics.

3. **Inaccurate Role Description:** The role of NICE and its health economists is grossly oversimplified in the statement. Their goal is to ensure treatments are both effective and cost-effective, without being influenced by external financial concerns of the biotech companies.

4. **Speculative and Misleading Tone:** The tone and content aim to provoke unwarranted fear and uncertainty about DCVAX-L's review process, which is typical of "short and distort" tactics where misinformation is spread to manipulate stock prices.

**Advisory:

**Beware of 'Short and Distort' Tactics:** Be cautious of speculative and unfounded statements designed to manipulate perceptions. These tactics are often used in attempts to influence stock prices by spreading negative rumors.

**Rely on Trustworthy Sources:** For accurate and reliable information about DCVAX-L and its regulatory status, consult peer-reviewed medical journals, official NICE documentation, and other authoritative sources like regulatory announcements.

By relying on credible, peer-reviewed sources and official statements, you can avoid being misled by reckless and harmful disinformation that seeks to distort the truth for speculative gain.

For the most accurate and reliable information, refer to the official NICE website (https://www.nice.org.uk/guidance/indevelopment/gid-ta10143) and trusted medical publications accessible through databases like https://pubmed.ncbi.nlm.nih.gov/


https://www.nature.com/articles/s41467-024-48073-y

https://www.jci.org/articles/view/169314

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
Bullish
Bullish

Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News